HOME >> MEDICINE >> NEWS
Emselex(R) receives positive CHMP opinion for the treatment of overactive bladder

Basel, 30th July 2004 Novartis Pharma AG announced today that the Committee for Medicinal Products for Human Use (CHMP), adopted a positive opinion recommending that the European Commission (EC) grant a Marketing Authorisation for Emselex (darifenacin hydrobromide), 7.5mg and 15mg, for the treatment of overactive bladder (OAB) in all 25 European Union (EU) countries as well as Norway and Iceland. Upon receipt of the EC approval, Novartis will be able to market Emselex throughout these countries.

"We are delighted by the CHMP's positive opinion for Emselex, to provide overactive bladder sufferers with a new safe and effective treatment option", said Jrg Reinhardt, Global Head of Development Novartis Pharma AG. "Due to its M3 selectivity, Emselex provides effective overactive bladder symptom relief while decreasing the potential risk of safety issues such as cognitive impairment or effects on cardiac function."

OAB affects almost one in six adults in Europe1. Symptoms of overactive bladder are urinary urgency (a sudden compelling desire to pass urine, which is difficult to defer) with or without urge incontinence (involuntary leakage accompanied by urgency), urinary frequency (voiding the bladder too often), and nocturia (waking at night one or more times to void the bladder).

The CHMP based its positive opinion on Emselex's comprehensive data package for OAB. The safety and efficacy of Emselex has been extensively studied in over 90 pre-clinical studies and clinical trials, involving more than 5,000 patients. Pivotal studies explored key endpoints including the reduction in the number of incontinence episodes per week, the reduction in the number of voluntary urination episodes (micturition) per day, the reduction in the episodes and severity of urgency and an increase in the average volume of urine passed per micturition.

The phase III clinical
'"/>


30-Jul-2004


Page: 1 2 3

Related medicine news :

1. UIC professor receives international humanitarian award
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
4. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
5. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
6. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
7. American Academy of Neurology program receives Grassroots Award
8. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2018)... (PRWEB) , ... November 08, 2018 , ... ... Shepherd Hospice , HPH Hospice and LifePath Hospice ) announced ... Officer on Monday, December 3, 2018. Forman will report directly to President and ...
(Date:11/8/2018)... ... November 08, 2018 , ... ... reported among different media sources could impact how they view advertising and earned ... (FMMS). Market Connections, Inc. will release results of the tenth annual study of ...
(Date:11/8/2018)... ... November 08, 2018 , ... Dutch Bros Coffee raised $421,440 ... Awareness Month. For each custom “Be Aware” mug sold in October, Dutch Bros donated ... proud of the support our customers showed for these amazing organizations,” said Travis Boersma, ...
(Date:11/8/2018)... ... November 08, 2018 , ... ... reduce re-hospitalizations and enhance disease management for high risk patients. , Porchlight VNA/Home ... are at risk for hospital readmissions and emergency department visits, primarily patients with ...
(Date:11/7/2018)... DALLAS (PRWEB) , ... November 07, 2018 , ... AccentCare, ... who have served our nation. , “We thank Veterans everywhere for ensuring our ... meet their particular home healthcare needs,” said AccentCare CEO Steve Rodgers, who was a ...
Breaking Medicine News(10 mins):
(Date:11/7/2018)... (PRWEB) , ... November 08, 2018 , ... “I Understand ... Parent Who Had Alzheimer’s”: a reflective memoir and family guide. “I Understand . . ... Pace, a senior information security and compliance executive born and raised in Detroit, Michigan. ...
(Date:11/7/2018)... Ga. (PRWEB) , ... November 07, 2018 , ... ... on Veterinary Technician Education and Activities (AVMA CVTEA), Ashworth College proudly announces the ... program. , “We're so proud to make the announcement,” said Margi Sirois, EdD, ...
(Date:11/7/2018)... ... November 07, 2018 , ... ... Biolabs and their leading sports performance ingredient, Fitnox™. GRAS (Generally Recognized As Safe) ... scientific evidence. Any new ingredient, or previously approved ingredient that is added for ...
Breaking Medicine Technology:
Cached News: